Upadacitinib Shows Positive Endoscopic Outcomes in Crohn ' s Disease Upadacitinib Shows Positive Endoscopic Outcomes in Crohn ' s Disease

Already FDA approved for ulcerative colitis, upadacitinib improves endoscopic response versus placebo in people with Crohn ' s disease, research shows.Medscape Medical News
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Gastroenterology News Source Type: news